Exact Mass: 420.2137
Exact Mass Matches: 420.2137
Found 500 metabolites which its exact mass value is equals to given mass value 420.2137
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Levocabastine
Levocabastine is only found in individuals that have used or taken this drug. It is a selective second-generation H1-receptor antagonist used for allergic conjunctivitis. Levocabastine was discovered at Janssen Pharmaceutica in 1979.Levocabastine is a potent, selective histamine H1-receptor antagonist. It works by competing with histamine for H1-receptor sites on effector cells. It thereby prevents, but does not reverse, responses mediated by histamine alone. Levocabastine does not block histamine release but, rather, prevents histamine binding and activity. Levocabastine also binds neurotensin 2 receptors and serves as a neurotensin agonist. This can induce some degree of analgesia. R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Armillane
Armillane is found in mushrooms. Armillane is a metabolite of Armillaria mellea (honey mushroom Metabolite of Armillaria mellea (honey mushroom). Armillane is found in mushrooms.
(8alpha,10alpha,13alpha,17beta)-17-[(4-Hydroxyphenyl)carbonyl]androsta-3,5-diene-3-carboxylic acid
Cabastine
D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists
DGAT-1 inhibitor 2
DGAT-1 inhibitor 2 is an effective inhibitor of DGAT-1;antiobesity agents. IC50 value: Target: DGAT-1 Acyl-CoA:diacylglycerol acyltransferase 1 (DGAT1) is one of two known DGAT enzymes that catalyze the final step in triglyceride synthesis. Findings from genetically modified mice as well as pharmacological studies suggest that inhibition of DGAT1 is a promising strategy for the treatment of obesity and type 2 diabetes.
Hexoprenaline
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents
Sibrafiban
D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
8-(3-(1-((3-Fluorophenyl)methyl)-4-piperidinyl)-1-oxopropyl)-1,2,5,6-tetrahydro-4h-pyrrolo(3,2,1-ij)quinolin-4-one
8-[3-[1-[(3-Fluorophenyl)methyl]-4-piperidinyl]-1-oxopropyl]-1,2,5,6-tetrahydro-4H-pyrrolo[3,2,1-ij]quinoline-4-one
Trichoverrol A
D009676 - Noxae > D011042 - Poisons > D014255 - Trichothecenes D009676 - Noxae > D011042 - Poisons > D009183 - Mycotoxins CONFIDENCE isolated standard
8beta-Acetoxy-3beta-angeloyloxy-5alpha-hydroxycostic acid methyl ester
Deacetylpseudolaric acid A 2,3-dihydroxypropyl ester
[4beta(2Z,4E,6S,7S)]- 12,13-Epoxytrichothec-9-ene-4,16-diol 4-(6,7-dihydroxy-2,4-octadienoate)
Trichoverrol B
[4beta(2Z,4E,6S,7R)]-12,13-Epoxytrichothec-9-ene-4,16-diol 4-(6,7-dihydroxy-2,4-octadienoate)
(5R,9aS,9bS)-9b-Hydroxy-6,6,9a-trimethyl-1-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-5-yl (2E,4E)-6,7-dihydroxy-2,4-octadienoate
4-Benzyl-2-({4-[5-(trifluoromethyl)-2-pyridinyl]piperazino}methyl)
aminophylline
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03D - Other systemic drugs for obstructive airway diseases > R03DA - Xanthines D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent > C319 - Bronchodilator D018377 - Neurotransmitter Agents > D058905 - Purinergic Agents > D058914 - Purinergic Antagonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents Aminophylline is a competitive and non-selective phosphodiesterase (PDE) inhibitor. Aminophylline is a competitive adenosine receptor antagonist. Aminophylline has apulmonary vasodilator action as well as a bronchodilator action and has the potential for asthma research[1][2].
3beta,5,12beta,14-Tetrahydroxy-19-oxo-5beta,14beta-card-20(22)-enolid|3beta,5,12beta,14-tetrahydroxy-19-oxo-5beta,14beta-card-20(22)-enolide|antiarigenin
17alpha-strophadogenin|5beta,14beta,16beta-trihydroxy-19-oxo-17alpha-card-20(22)-enolide
rel-(7S,8R,1R,3S,4S,5S)-Delta8-4-hydroxy-3,4,5,3,5-pentamethoxy-1,2,3,4,5,6-hexahydro-2-oxo-7.3,8.1-neolignan
9alpha-hydroxy-6beta-(6,6-dimethoxyhex-2E,4E-dienoyloxy)-5alpha-drim-7-en-11,12-olide|ustusolate D
9beta-hydroxy-14-isobutyryloxyalbicolide-15-O-isobutyrate
3alpha,5beta,6alpha-trihydroxy-4alpha-(beta-D-glucopyranosyloxy)-7-megastigmen-9-one|youngiajaponicoside C
20(R)-15alpha-acetoxy-6beta-hydroxy-20-methoxy-6,20alpha-epoxy-6,7-seco-1alpha,7-olide-ent-kaur-16-ene|20(S)-15alpha-acetoxy-6beta -hydroxy-20-methoxy-6,20alpha-epoxy-6,7-seco-ent-kanr-16-en-1alpha,7-olide|isodonhenrin B|isorosthin C
1alpha-acetoxy-5alpha,7beta-dihydroxy-12alpha-methoxycassa-14(17),13(15)-dien-16,12-olide|caesalpin G
Caesalpine A
(7R,8S,2R,3R,4R,5S)-Delta(8)-2,4-dihydroxy-3,4,5,3,5-pentamethoxy-2,3,4,5-tetrahydro-2-oxo-7.3,8.5-neolignan|nectamazin C
1alpha-Hydroxy-6-O-isobutyryl-3beta-isobutyryloxysteiractinolid
[(5R,9aS,9bS)-9b-hydroxy-6,6,9a-trimethyl-1-oxo-3,5,5a,7,8,9-hexahydrobenzo[e][2]benzofuran-5-yl] (2E,4E)-6,7-dihydroxyocta-2,4-dienoate
6-[(2E,6E)-4,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-2,6-dien-2-yl]-4-methoxy-5-methylpyran-2-one
C23H32O7_(5R,9aS,9bS)-9b-Hydroxy-6,6,9a-trimethyl-1-oxo-1,3,5,5a,6,7,8,9,9a,9b-decahydronaphtho[1,2-c]furan-5-yl (2E,4E)-6,7-dihydroxy-2,4-octadienoate
C23H32O7_1-Phenanthrenecarboxylic acid, 10-(acetyloxy)-1,2,3,4,4a,9,10,10a-octahydro-4,5,9-trihydroxy-1,4a-dimethyl-7-(1-methylethyl)-, methyl ester
methyl 10-acetyloxy-4,5,9-trihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate
6-[(2E,6E)-4,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-2,6-dien-2-yl]-4-methoxy-5-methylpyran-2-one [IIN-based: Match]
6-[(2E,6E)-4,5-dihydroxy-4,6-dimethyl-7-(1,2,4-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-4-yl)hepta-2,6-dien-2-yl]-4-methoxy-5-methylpyran-2-one [IIN-based on: CCMSLIB00000848593]
methyl 10-acetyloxy-4,5,9-trihydroxy-1,4a-dimethyl-7-propan-2-yl-2,3,4,9,10,10a-hexahydrophenanthrene-1-carboxylate_major
Ala Ala Pro Tyr
Ala Ala Tyr Pro
Ala Phe Pro Ser
Ala Phe Ser Pro
Ala His Pro Pro
Ala Ile Met Ser
Ala Ile Ser Met
Ala Leu Met Ser
Ala Leu Ser Met
Ala Met Ile Ser
Ala Met Leu Ser
Ala Met Ser Ile
Ala Met Ser Leu
Ala Met Thr Val
Ala Met Val Thr
Ala Pro Ala Tyr
Ala Pro Phe Ser
Ala Pro His Pro
Ala Pro Pro His
Ala Pro Ser Phe
Ala Pro Tyr Ala
Ala Ser Phe Pro
Ala Ser Ile Met
Ala Ser Leu Met
Ala Ser Met Ile
Ala Ser Met Leu
Ala Ser Pro Phe
Ala Thr Met Val
Ala Thr Val Met
Ala Val Met Thr
Ala Val Thr Met
Ala Tyr Ala Pro
Ala Tyr Pro Ala
Cys Ile Ser Val
Cys Ile Val Ser
Cys Leu Ser Val
Cys Leu Val Ser
Cys Ser Ile Val
Cys Ser Leu Val
Cys Ser Val Ile
Cys Ser Val Leu
Cys Thr Val Val
Cys Val Ile Ser
Cys Val Leu Ser
Cys Val Ser Ile
Cys Val Ser Leu
Cys Val Thr Val
Cys Val Val Thr
Phe Ala Pro Ser
Phe Ala Ser Pro
Phe Gly Pro Thr
Phe Gly Thr Pro
Phe Pro Ala Ser
Phe Pro Gly Thr
Phe Pro Ser Ala
Phe Pro Thr Gly
Phe Ser Ala Pro
Phe Ser Pro Ala
Phe Thr Gly Pro
Phe Thr Pro Gly
Gly Phe Pro Thr
Gly Phe Thr Pro
Gly Ile Met Thr
Gly Ile Thr Met
Gly Leu Met Thr
Gly Leu Thr Met
Gly Met Ile Thr
Gly Met Leu Thr
Gly Met Thr Ile
Gly Met Thr Leu
Gly Pro Phe Thr
Gly Pro Thr Phe
Gly Thr Phe Pro
Gly Thr Ile Met
Gly Thr Leu Met
Gly Thr Met Ile
Gly Thr Met Leu
Gly Thr Pro Phe
His Ala Pro Pro
His Pro Ala Pro
His Pro Pro Ala
Ile Ala Met Ser
Ile Ala Ser Met
Ile Cys Ser Val
Ile Cys Val Ser
Ile Gly Met Thr
Ile Gly Thr Met
Ile Met Ala Ser
Ile Met Gly Thr
Ile Met Ser Ala
Ile Met Thr Gly
Ile Ser Ala Met
Ile Ser Cys Val
Ile Ser Met Ala
Ile Ser Thr Thr
Ile Ser Val Cys
Ile Thr Gly Met
Ile Thr Met Gly
Ile Thr Ser Thr
Ile Thr Thr Ser
Ile Val Cys Ser
Ile Val Ser Cys
Leu Ala Met Ser
Leu Ala Ser Met
Leu Cys Ser Val
Leu Cys Val Ser
Leu Gly Met Thr
Leu Gly Thr Met
Leu Met Ala Ser
Leu Met Gly Thr
Leu Met Ser Ala
Leu Met Thr Gly
Leu Ser Ala Met
Leu Ser Cys Val
Leu Ser Met Ala
Leu Ser Thr Thr
Leu Ser Val Cys
Leu Thr Gly Met
Leu Thr Met Gly
Leu Thr Ser Thr
Leu Thr Thr Ser
Leu Val Cys Ser
Leu Val Ser Cys
Met Ala Ile Ser
Met Ala Leu Ser
Met Ala Ser Ile
Met Ala Ser Leu
Met Ala Thr Val
Met Ala Val Thr
Met Gly Ile Thr
Met Gly Leu Thr
Met Gly Thr Ile
Met Gly Thr Leu
Met Ile Ala Ser
Met Ile Gly Thr
Met Ile Ser Ala
Met Ile Thr Gly
Met Leu Ala Ser
Met Leu Gly Thr
Met Leu Ser Ala
Met Leu Thr Gly
Met Ser Ala Ile
Met Ser Ala Leu
Met Ser Ile Ala
Met Ser Leu Ala
Met Thr Ala Val
Met Thr Gly Ile
Met Thr Gly Leu
Met Thr Ile Gly
Met Thr Leu Gly
Met Thr Val Ala
Met Val Ala Thr
Met Val Thr Ala
Pro Ala Ala Tyr
Pro Ala Phe Ser
Pro Ala His Pro
Pro Ala Pro His
Pro Ala Ser Phe
Pro Ala Tyr Ala
Pro Phe Ala Ser
Pro Phe Gly Thr
Pro Phe Ser Ala
Pro Phe Thr Gly
Pro Gly Phe Thr
Pro Gly Thr Phe
Pro His Ala Pro
Pro His Pro Ala
Pro Pro Ala His
Pro Pro His Ala
Pro Ser Ala Phe
Pro Ser Phe Ala
Pro Thr Phe Gly
Pro Thr Gly Phe
Pro Tyr Ala Ala
Ser Ala Phe Pro
Ser Ala Ile Met
Ser Ala Leu Met
Ser Ala Met Ile
Ser Ala Met Leu
Ser Ala Pro Phe
Ser Cys Ile Val
Ser Cys Leu Val
Ser Cys Val Ile
Ser Cys Val Leu
Ser Phe Ala Pro
Ser Phe Pro Ala
Ser Ile Ala Met
Ser Ile Cys Val
Ser Ile Met Ala
Ser Ile Thr Thr
Ser Ile Val Cys
Ser Leu Ala Met
Ser Leu Cys Val
Ser Leu Met Ala
Ser Leu Thr Thr
Ser Leu Val Cys
Ser Met Ala Ile
Ser Met Ala Leu
Ser Met Ile Ala
Ser Met Leu Ala
Ser Pro Ala Phe
Ser Pro Phe Ala
Ser Thr Ile Thr
Ser Thr Leu Thr
Ser Thr Thr Ile
Ser Thr Thr Leu
Ser Val Cys Ile
Ser Val Cys Leu
Ser Val Ile Cys
Ser Val Leu Cys
Thr Ala Met Val
Thr Ala Val Met
Thr Cys Val Val
Thr Phe Gly Pro
Thr Phe Pro Gly
Thr Gly Phe Pro
Thr Gly Ile Met
Thr Gly Leu Met
Thr Gly Met Ile
Thr Gly Met Leu
Thr Gly Pro Phe
Thr Ile Gly Met
Thr Ile Met Gly
Thr Ile Ser Thr
Thr Ile Thr Ser
Thr Leu Gly Met
Thr Leu Met Gly
Thr Leu Ser Thr
Thr Leu Thr Ser
Thr Met Ala Val
Thr Met Gly Ile
Thr Met Gly Leu
Thr Met Ile Gly
Thr Met Leu Gly
Thr Met Val Ala
Thr Pro Phe Gly
Thr Pro Gly Phe
Thr Ser Ile Thr
Thr Ser Leu Thr
Thr Ser Thr Ile
Thr Ser Thr Leu
Thr Thr Ile Ser
Thr Thr Leu Ser
Thr Thr Ser Ile
Thr Thr Ser Leu
Thr Thr Thr Val
Thr Thr Val Thr
Thr Val Ala Met
Thr Val Cys Val
Thr Val Met Ala
Thr Val Thr Thr
Thr Val Val Cys
Val Ala Met Thr
Val Ala Thr Met
Val Cys Ile Ser
Val Cys Leu Ser
Val Cys Ser Ile
Val Cys Ser Leu
Val Cys Thr Val
Val Cys Val Thr
Val Ile Cys Ser
Val Ile Ser Cys
Val Leu Cys Ser
Val Leu Ser Cys
Val Met Ala Thr
Val Met Thr Ala
Val Ser Cys Ile
Val Ser Cys Leu
Val Ser Ile Cys
Val Ser Leu Cys
Val Thr Ala Met
Val Thr Cys Val
Val Thr Met Ala
Val Thr Thr Thr
Val Thr Val Cys
Val Val Cys Thr
Val Val Thr Cys
Tyr Ala Ala Pro
Tyr Ala Pro Ala
Tyr Pro Ala Ala
Cabastine
R - Respiratory system > R01 - Nasal preparations > R01A - Decongestants and other nasal preparations for topical use > R01AC - Antiallergic agents, excl. corticosteroids D018377 - Neurotransmitter Agents > D018494 - Histamine Agents > D006633 - Histamine Antagonists S - Sensory organs > S01 - Ophthalmologicals > S01G - Decongestants and antiallergics C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
sodium 2-[2-[2-(dodecyloxy)ethoxy]ethoxy]ethyl sulphate
9-O-(1,2:5,6-Di-O-isopropylidene-alpha-D-glucofuranosyl)-9-boratabicyclo[3.3.1]nonane potassium salt
1-BOC-4-(2-CBZ-AMINO-2-METHOXYCARBONYL-ETHYL)PIPERIDINE
Ethyl (Z)-((1-(N-((p-hydroxyamidino)benzoyl)-L-alanyl)-4-piperidyl)oxy)acetate
C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors
Methyl 6-(acetyloxy)-1,7,11-trihydroxyabieta-8(14),9(11),12-trien-18-oate
Hexoprenaline
R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03C - Adrenergics for systemic use > R03CC - Selective beta-2-adrenoreceptor agonists R - Respiratory system > R03 - Drugs for obstructive airway diseases > R03A - Adrenergics, inhalants > R03AC - Selective beta-2-adrenoreceptor agonists D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D012102 - Reproductive Control Agents > D015149 - Tocolytic Agents
tert-butyl 4-[5-(4-phenoxyphenyl)-1H-pyrazol-3-yl]piperazine-1-carboxylate
[(5R,9aS,9bS)-9b-hydroxy-6,6,9a-trimethyl-1-oxo-3,5,5a,7,8,9-hexahydrobenzo[e][2]benzofuran-5-yl] (2E,4E)-6,7-dihydroxyocta-2,4-dienoate
1-[1-[1-(1,3-Benzodioxol-5-ylmethyl)-5-tetrazolyl]-2-methylpropyl]-4-phenylpiperazine
6-[(2E,6E)-4,5-Dihydroxy-4,6-dimethyl-7-(2,4,5-trimethyl-3,6-dioxabicyclo[3.1.0]hexan-2-yl)hepta-2,6-dien-2-yl]-4-methoxy-5-methylpyran-2-one
2-[(2S,3R,6S)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2S,3S,6R)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
(4S,7S)-4-[(4-methoxyphenyl)methyl]-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
(5S,8S)-8-[(4-methoxyphenyl)methyl]-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(5S,8R)-8-[(4-methoxyphenyl)methyl]-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
1-[(1R,2aR,8bR)-1-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-phenylethanone
1-[(1S,2aR,8bR)-1-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-phenylethanone
1-[(1R)-1-(hydroxymethyl)-7-methoxy-1-spiro[1,2,3,9-tetrahydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(3-pyridinyl)ethanone
1-[(2S,3R)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methoxyphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
1-[(2R,3R)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methoxyphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
N-(2-hydroxyphenyl)-N-[(E)-(1-methylindol-3-yl)methylideneamino]octanediamide
2-[(2S,3R,6R)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2R,3S,6S)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2R,3S,6R)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2R,3R,6S)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2S,3S,6S)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
2-[(2R,3R,6R)-3-[[(4-fluoroanilino)-oxomethyl]amino]-2-(hydroxymethyl)-3,6-dihydro-2H-pyran-6-yl]-N-[2-(1-pyrrolidinyl)ethyl]acetamide
(4R,7S)-4-[(4-methoxyphenyl)methyl]-7-(phenylmethyl)-9-oxa-1,6,12,13-tetrazabicyclo[9.2.1]tetradeca-11(14),12-dien-5-one
(5R,8S)-8-[(4-methoxyphenyl)methyl]-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
(5R,8R)-8-[(4-methoxyphenyl)methyl]-5-(phenylmethyl)-3-oxa-1,6,13,14-tetrazabicyclo[9.3.0]tetradeca-11,13-dien-7-one
1-[(1S,2aS,8bS)-1-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-phenylethanone
1-[(1R,2aS,8bS)-1-(hydroxymethyl)-4-[4-oxanyl(oxo)methyl]-1,2a,3,8b-tetrahydroazeto[2,3-c]quinolin-2-yl]-2-phenylethanone
1-[(2R,3S)-1-[cyclopropyl(oxo)methyl]-2-(hydroxymethyl)-3-[4-(3-methoxyphenyl)phenyl]-1,6-diazaspiro[3.3]heptan-6-yl]ethanone
(2-hydroxy-3-phosphonooxypropyl) (9Z,12Z)-heptadeca-9,12-dienoate
(8xi,9xi,14xi,17xi)-3,5,14,19-Tetrahydroxy-19-oxocard-20(22)-enolide
2-hydroxy-1,3-dimethoxy-6-methyl-5-(prop-2-en-1-yl)-7-(3,4,5-trimethoxyphenyl)bicyclo[3.2.1]octan-8-one
(1r,2r,3as,3br,5as,7r,8r,9ar,9bs,11ar)-2,3a,7,8-tetrahydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-tetradecahydrocyclopenta[a]phenanthrene-9a-carbaldehyde
11'-(acetyloxy)-1',5'-dimethyl-8'-oxaspiro[oxirane-2,12'-tricyclo[7.2.1.0²,⁷]dodecan]-5'-en-2'-ylmethyl 5-hydroxy-3-methylpent-2-enoate
2,4,8-trimethyl (1r,2s,3r,4r,6r,8r,9r,12r)-6-hydroxy-4-methyl-13-methylidenetetracyclo[10.2.1.0¹,⁹.0³,⁸]pentadecane-2,4,8-tricarboxylate
2a,4-dihydroxy-3-(hydroxymethyl)-6,6,7b-trimethyl-octahydrocyclobuta[e]inden-2-yl 2,4-dihydroxy-6-methylbenzoate
(2s)-2-{[(2s)-1,2-dihydroxy-3-phenylpropylidene]amino}-3-[2-(2-methylbut-3-en-2-yl)-1h-indol-3-yl]propanoic acid
(5-hydroxy-3-methylidene-6-{[(2-methylpropanoyl)oxy]methyl}-2-oxo-3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-10-yl)methyl 2-methylpropanoate
(2r)-2,3-dihydroxypropyl (2e,4e)-5-[(1r,7s,8r,9r)-7-hydroxy-4,9-dimethyl-11-oxo-10-oxatricyclo[6.3.2.0¹,⁷]tridec-3-en-9-yl]-2-methylpenta-2,4-dienoate
(1r,3as,3br,5as,7s,9as,9bs,11r,11as)-3a,5a,7,11-tetrahydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde
5-[(2s,3s)-3-[(3,4-dimethoxyphenyl)methyl]-4-methoxy-2-(methoxymethyl)butyl]-3-methoxybenzene-1,2-diol
n-{1-[6-(ethylsulfanyl)-3,4,5-trihydroxyoxan-2-yl]-2-hydroxypropyl}-1-methyl-4-propylpyrrolidine-2-carboximidic acid
(1r,3as,5as,7s,9as,11r,11as)-3a,5a,7,11-tetrahydroxy-11a-methyl-1-(5-oxo-2h-furan-3-yl)-dodecahydro-1h-cyclopenta[a]phenanthrene-9a-carbaldehyde
antiarigenin
{"Ingredient_id": "HBIN016303","Ingredient_name": "antiarigenin","Alias": "NA","Ingredient_formula": "C23H32O7","Ingredient_Smile": "CC12C(CCC1(C3CCC4(CC(CCC4(C3CC2O)C=O)O)O)O)C5=CC(=O)OC5","Ingredient_weight": "420.5 g/mol","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "1375","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "11875953","DrugBank_id": "NA"}